Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T H Corbett

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Journal of Medicinal Chemistry|May 18, 2001
Design, synthesis, and biological evaluation of analogues of the antitumor agent, 2-(4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy)propionic acid (XK469)S T Hazeldine, L Polin, J Kushner, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1983
In vivo 31P NMR study of the metabolism of murine mammary 16/C adenocarcinoma and its response to chemotherapy, x-radiation, and hyperthermiaW T Evanochko, T C Ng, M B Lilly, et al.
Investigational New Drugs|July 30, 1999
Preclinical antitumor activity of XK469 (NSC 656889)P M LoRusso, R Parchment, L Demchik, et al.
Cancer Research|August 15, 1990
Antitumor efficacy of PD115934 (NSC 366140) against solid tumors of miceP LoRusso, A J Wozniak, L Polin, et al.
Journal of Medicinal Chemistry|November 12, 1993
Comparative molecular field analysis of in vitro growth inhibition of L1210 and HCT-8 cells by some pyrazoloacridinesJ P Horwitz, I Massova, T E Wiese, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 1999
Synthesis and biological evaluation of novel cryptophycin analogs with modification in the beta-alanine regionC Shih, L S Gossett, J M Gruber, et al.
Journal of Natural Products|September 28, 1998
Symplostatin 1: A dolastatin 10 analogue from the marine cyanobacterium Symploca hydnoidesG G Harrigan, H Luesch, W Y Yoshida, et al.
Biochemical Pharmacology|June 29, 1995
Mechanism of action and antitumor activity of (S)-10-(2,6-dimethyl-4-pyridinyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7 H- pyridol[1,2,3-de]-[1,4]benzothiazine-6-carboxylic acid (WIN 58161)S A Coughlin, D W Danz, R G Robinson, et al.
Investigational New Drugs|January 1, 1997
Treatment of human prostate tumors PC-3 and TSU-PR1 with standard and investigational agents in SCID miceL Polin, F Valeriote, K White, et al.
Journal of Natural Products|October 24, 1998
Isolation, structure determination, and biological activity of dolastatin 12 and lyngbyastatin 1 from Lyngbya majuscula/Schizothrix calcicola cyanobacterial assemblagesG G Harrigan, W Y Yoshida, R E Moore, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Journal of Medicinal Chemistry|May 18, 2001
Design, synthesis, and biological evaluation of analogues of the antitumor agent, 2-(4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy)propionic acid (XK469)S T Hazeldine, L Polin, J Kushner, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1983
In vivo 31P NMR study of the metabolism of murine mammary 16/C adenocarcinoma and its response to chemotherapy, x-radiation, and hyperthermiaW T Evanochko, T C Ng, M B Lilly, et al.
Investigational New Drugs|July 30, 1999
Preclinical antitumor activity of XK469 (NSC 656889)P M LoRusso, R Parchment, L Demchik, et al.
Cancer Research|August 15, 1990
Antitumor efficacy of PD115934 (NSC 366140) against solid tumors of miceP LoRusso, A J Wozniak, L Polin, et al.
Journal of Medicinal Chemistry|November 12, 1993
Comparative molecular field analysis of in vitro growth inhibition of L1210 and HCT-8 cells by some pyrazoloacridinesJ P Horwitz, I Massova, T E Wiese, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 1999
Synthesis and biological evaluation of novel cryptophycin analogs with modification in the beta-alanine regionC Shih, L S Gossett, J M Gruber, et al.
Journal of Natural Products|September 28, 1998
Symplostatin 1: A dolastatin 10 analogue from the marine cyanobacterium Symploca hydnoidesG G Harrigan, H Luesch, W Y Yoshida, et al.
Biochemical Pharmacology|June 29, 1995
Mechanism of action and antitumor activity of (S)-10-(2,6-dimethyl-4-pyridinyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7 H- pyridol[1,2,3-de]-[1,4]benzothiazine-6-carboxylic acid (WIN 58161)S A Coughlin, D W Danz, R G Robinson, et al.
Investigational New Drugs|January 1, 1997
Treatment of human prostate tumors PC-3 and TSU-PR1 with standard and investigational agents in SCID miceL Polin, F Valeriote, K White, et al.
Journal of Natural Products|October 24, 1998
Isolation, structure determination, and biological activity of dolastatin 12 and lyngbyastatin 1 from Lyngbya majuscula/Schizothrix calcicola cyanobacterial assemblagesG G Harrigan, W Y Yoshida, R E Moore, et al.
Pageof 10